nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—type 2 diabetes mellitus—atherosclerosis	0.441	1	CtDrD
Rosiglitazone—PPARG—atherosclerosis	0.144	0.727	CbGaD
Rosiglitazone—ALB—atherosclerosis	0.054	0.273	CbGaD
Rosiglitazone—SLCO1B1—Ezetimibe—atherosclerosis	0.0269	0.104	CbGbCtD
Rosiglitazone—SLCO1B1—Rosuvastatin—atherosclerosis	0.0269	0.104	CbGbCtD
Rosiglitazone—SLCO1B1—Simvastatin—atherosclerosis	0.025	0.0965	CbGbCtD
Rosiglitazone—SLCO1B1—Lovastatin—atherosclerosis	0.0244	0.0944	CbGbCtD
Rosiglitazone—SLCO1B1—Pravastatin—atherosclerosis	0.0244	0.0944	CbGbCtD
Rosiglitazone—ALB—Rosuvastatin—atherosclerosis	0.0147	0.0568	CbGbCtD
Rosiglitazone—CYP2C8—Simvastatin—atherosclerosis	0.0106	0.0408	CbGbCtD
Rosiglitazone—CYP2C8—Lovastatin—atherosclerosis	0.0103	0.04	CbGbCtD
Rosiglitazone—CYP2C8—Pravastatin—atherosclerosis	0.0103	0.04	CbGbCtD
Rosiglitazone—CYP2C19—Rosuvastatin—atherosclerosis	0.00954	0.0368	CbGbCtD
Rosiglitazone—CYP2C19—Simvastatin—atherosclerosis	0.00887	0.0343	CbGbCtD
Rosiglitazone—CYP2C19—Lovastatin—atherosclerosis	0.00868	0.0335	CbGbCtD
Rosiglitazone—CYP2D6—Niacin—atherosclerosis	0.00853	0.0329	CbGbCtD
Rosiglitazone—CYP2C9—Rosuvastatin—atherosclerosis	0.00793	0.0306	CbGbCtD
Rosiglitazone—CYP2C9—Simvastatin—atherosclerosis	0.00737	0.0285	CbGbCtD
Rosiglitazone—CYP2C9—Pravastatin—atherosclerosis	0.00722	0.0279	CbGbCtD
Rosiglitazone—CYP2C9—Lovastatin—atherosclerosis	0.00722	0.0279	CbGbCtD
Rosiglitazone—CYP2D6—Simvastatin—atherosclerosis	0.00674	0.026	CbGbCtD
Rosiglitazone—CYP2D6—Pravastatin—atherosclerosis	0.0066	0.0255	CbGbCtD
Rosiglitazone—CYP2D6—Lovastatin—atherosclerosis	0.0066	0.0255	CbGbCtD
Rosiglitazone—Macular oedema—Niacin—atherosclerosis	0.0021	0.0509	CcSEcCtD
Rosiglitazone—PPARG—leg—atherosclerosis	0.00155	0.118	CbGeAlD
Rosiglitazone—PPARG—hindlimb—atherosclerosis	0.00139	0.106	CbGeAlD
Rosiglitazone—PPARG—appendage—atherosclerosis	0.00119	0.0905	CbGeAlD
Rosiglitazone—PPARG—artery—atherosclerosis	0.000849	0.0647	CbGeAlD
Rosiglitazone—ACSL4—connective tissue—atherosclerosis	0.000754	0.0574	CbGeAlD
Rosiglitazone—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.000744	0.0181	CcSEcCtD
Rosiglitazone—PPARG—endothelium—atherosclerosis	0.000718	0.0546	CbGeAlD
Rosiglitazone—PPARG—blood vessel—atherosclerosis	0.000662	0.0504	CbGeAlD
Rosiglitazone—ACSL4—cardiovascular system—atherosclerosis	0.000656	0.05	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—atherosclerosis	0.0006	0.286	CrCbGaD
Rosiglitazone—Chloropyramine—HRH1—atherosclerosis	0.000589	0.281	CrCbGaD
Rosiglitazone—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.000587	0.0143	CcSEcCtD
Rosiglitazone—ACSL4—adipose tissue—atherosclerosis	0.000579	0.0441	CbGeAlD
Rosiglitazone—Hepatic failure—Rosuvastatin—atherosclerosis	0.000568	0.0138	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Niacin—atherosclerosis	0.000563	0.0137	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Lovastatin—atherosclerosis	0.000495	0.012	CcSEcCtD
Rosiglitazone—Fluid retention—Niacin—atherosclerosis	0.000486	0.0118	CcSEcCtD
Rosiglitazone—Hepatic failure—Lovastatin—atherosclerosis	0.000481	0.0117	CcSEcCtD
Rosiglitazone—Hepatic failure—Ezetimibe—atherosclerosis	0.000472	0.0115	CcSEcCtD
Rosiglitazone—Mepyramine—HRH1—atherosclerosis	0.000471	0.225	CrCbGaD
Rosiglitazone—Diabetes mellitus—Simvastatin—atherosclerosis	0.000465	0.0113	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000463	0.0112	CcSEcCtD
Rosiglitazone—PTGS1—artery—atherosclerosis	0.000454	0.0346	CbGeAlD
Rosiglitazone—Hepatic failure—Simvastatin—atherosclerosis	0.00045	0.0109	CcSEcCtD
Rosiglitazone—Tripelennamine—HRH1—atherosclerosis	0.000435	0.208	CrCbGaD
Rosiglitazone—Diabetes mellitus—Niacin—atherosclerosis	0.000427	0.0104	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Niacin—atherosclerosis	0.000425	0.0103	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000419	0.0102	CcSEcCtD
Rosiglitazone—Hepatic failure—Pravastatin—atherosclerosis	0.000407	0.00989	CcSEcCtD
Rosiglitazone—ACSL4—liver—atherosclerosis	0.000406	0.0309	CbGeAlD
Rosiglitazone—PTGS1—endothelium—atherosclerosis	0.000384	0.0292	CbGeAlD
Rosiglitazone—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000379	0.00922	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000372	0.00904	CcSEcCtD
Rosiglitazone—Sinusitis—Rosuvastatin—atherosclerosis	0.000369	0.00896	CcSEcCtD
Rosiglitazone—PTGS1—blood vessel—atherosclerosis	0.000354	0.0269	CbGeAlD
Rosiglitazone—Hepatitis—Rosuvastatin—atherosclerosis	0.000353	0.00858	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000341	0.00828	CcSEcCtD
Rosiglitazone—PPARG—connective tissue—atherosclerosis	0.000339	0.0258	CbGeAlD
Rosiglitazone—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000331	0.00803	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Pravastatin—atherosclerosis	0.000327	0.00795	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000325	0.00789	CcSEcCtD
Rosiglitazone—Sinusitis—Lovastatin—atherosclerosis	0.000313	0.0076	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000309	0.00751	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000309	0.00751	CcSEcCtD
Rosiglitazone—Sinusitis—Ezetimibe—atherosclerosis	0.000307	0.00745	CcSEcCtD
Rosiglitazone—CYP2A6—adipose tissue—atherosclerosis	0.000306	0.0233	CbGeAlD
Rosiglitazone—Hepatitis—Lovastatin—atherosclerosis	0.000299	0.00727	CcSEcCtD
Rosiglitazone—PPARG—cardiovascular system—atherosclerosis	0.000295	0.0225	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000294	0.00714	CcSEcCtD
Rosiglitazone—Hepatitis—Ezetimibe—atherosclerosis	0.000294	0.00713	CcSEcCtD
Rosiglitazone—Sinusitis—Simvastatin—atherosclerosis	0.000293	0.00711	CcSEcCtD
Rosiglitazone—Oedema peripheral—Ezetimibe—atherosclerosis	0.000289	0.00702	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000288	0.00701	CcSEcCtD
Rosiglitazone—Weight increased—Pravastatin—atherosclerosis	0.000288	0.00699	CcSEcCtD
Rosiglitazone—Erythema multiforme—Lovastatin—atherosclerosis	0.000283	0.00687	CcSEcCtD
Rosiglitazone—Angioedema—Rosuvastatin—atherosclerosis	0.000281	0.00682	CcSEcCtD
Rosiglitazone—Hepatitis—Simvastatin—atherosclerosis	0.00028	0.0068	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00028	0.00679	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000278	0.00675	CcSEcCtD
Rosiglitazone—Erythema multiforme—Ezetimibe—atherosclerosis	0.000278	0.00674	CcSEcCtD
Rosiglitazone—Myocardial infarction—Pravastatin—atherosclerosis	0.000276	0.00671	CcSEcCtD
Rosiglitazone—Immune system disorder—Ezetimibe—atherosclerosis	0.000265	0.00644	CcSEcCtD
Rosiglitazone—Erythema multiforme—Simvastatin—atherosclerosis	0.000265	0.00643	CcSEcCtD
Rosiglitazone—Sinusitis—Pravastatin—atherosclerosis	0.000264	0.00642	CcSEcCtD
Rosiglitazone—Arthralgia—Rosuvastatin—atherosclerosis	0.000262	0.00636	CcSEcCtD
Rosiglitazone—Myalgia—Rosuvastatin—atherosclerosis	0.000262	0.00636	CcSEcCtD
Rosiglitazone—PPARG—adipose tissue—atherosclerosis	0.00026	0.0198	CbGeAlD
Rosiglitazone—Hepatitis—Niacin—atherosclerosis	0.000257	0.00624	CcSEcCtD
Rosiglitazone—Malnutrition—Ezetimibe—atherosclerosis	0.000256	0.00621	CcSEcCtD
Rosiglitazone—Oedema peripheral—Niacin—atherosclerosis	0.000253	0.00615	CcSEcCtD
Rosiglitazone—Hepatitis—Pravastatin—atherosclerosis	0.000253	0.00615	CcSEcCtD
Rosiglitazone—Back pain—Lovastatin—atherosclerosis	0.000252	0.00612	CcSEcCtD
Rosiglitazone—Infection—Rosuvastatin—atherosclerosis	0.000249	0.00605	CcSEcCtD
Rosiglitazone—Back pain—Ezetimibe—atherosclerosis	0.000247	0.006	CcSEcCtD
Rosiglitazone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000246	0.00598	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000246	0.00597	CcSEcCtD
Rosiglitazone—Eye disorder—Niacin—atherosclerosis	0.00024	0.00583	CcSEcCtD
Rosiglitazone—Erythema multiforme—Pravastatin—atherosclerosis	0.000239	0.00581	CcSEcCtD
Rosiglitazone—Angioedema—Lovastatin—atherosclerosis	0.000238	0.00578	CcSEcCtD
Rosiglitazone—Anaemia—Ezetimibe—atherosclerosis	0.000236	0.00574	CcSEcCtD
Rosiglitazone—Cardiac disorder—Pravastatin—atherosclerosis	0.000235	0.0057	CcSEcCtD
Rosiglitazone—Angioedema—Ezetimibe—atherosclerosis	0.000233	0.00567	CcSEcCtD
Rosiglitazone—Leukopenia—Lovastatin—atherosclerosis	0.000233	0.00566	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000229	0.00555	CcSEcCtD
Rosiglitazone—Anaemia—Simvastatin—atherosclerosis	0.000225	0.00547	CcSEcCtD
Rosiglitazone—Malnutrition—Niacin—atherosclerosis	0.000224	0.00543	CcSEcCtD
Rosiglitazone—Angioedema—Simvastatin—atherosclerosis	0.000223	0.00541	CcSEcCtD
Rosiglitazone—Arthralgia—Lovastatin—atherosclerosis	0.000222	0.00539	CcSEcCtD
Rosiglitazone—Myalgia—Lovastatin—atherosclerosis	0.000222	0.00539	CcSEcCtD
Rosiglitazone—Hypertension—Ezetimibe—atherosclerosis	0.000221	0.00536	CcSEcCtD
Rosiglitazone—Leukopenia—Simvastatin—atherosclerosis	0.000218	0.0053	CcSEcCtD
Rosiglitazone—Arthralgia—Ezetimibe—atherosclerosis	0.000218	0.00528	CcSEcCtD
Rosiglitazone—Myalgia—Ezetimibe—atherosclerosis	0.000218	0.00528	CcSEcCtD
Rosiglitazone—Constipation—Rosuvastatin—atherosclerosis	0.000215	0.00521	CcSEcCtD
Rosiglitazone—CYP2A6—liver—atherosclerosis	0.000214	0.0163	CbGeAlD
Rosiglitazone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000213	0.00516	CcSEcCtD
Rosiglitazone—SLCO1B1—liver—atherosclerosis	0.000212	0.0161	CbGeAlD
Rosiglitazone—Infection—Lovastatin—atherosclerosis	0.000211	0.00513	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000209	0.00507	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000208	0.00506	CcSEcCtD
Rosiglitazone—Arthralgia—Simvastatin—atherosclerosis	0.000207	0.00504	CcSEcCtD
Rosiglitazone—Myalgia—Simvastatin—atherosclerosis	0.000207	0.00504	CcSEcCtD
Rosiglitazone—Infection—Ezetimibe—atherosclerosis	0.000207	0.00503	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000205	0.00497	CcSEcCtD
Rosiglitazone—Angioedema—Niacin—atherosclerosis	0.000204	0.00497	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000204	0.00496	CcSEcCtD
Rosiglitazone—Anaemia—Pravastatin—atherosclerosis	0.000204	0.00495	CcSEcCtD
Rosiglitazone—Angioedema—Pravastatin—atherosclerosis	0.000201	0.00489	CcSEcCtD
Rosiglitazone—Leukopenia—Niacin—atherosclerosis	0.0002	0.00486	CcSEcCtD
Rosiglitazone—Urticaria—Rosuvastatin—atherosclerosis	0.000199	0.00484	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000199	0.00483	CcSEcCtD
Rosiglitazone—Oedema—Simvastatin—atherosclerosis	0.000199	0.00483	CcSEcCtD
Rosiglitazone—Infection—Simvastatin—atherosclerosis	0.000198	0.0048	CcSEcCtD
Rosiglitazone—Leukopenia—Pravastatin—atherosclerosis	0.000197	0.00479	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000195	0.00473	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000194	0.00471	CcSEcCtD
Rosiglitazone—Arthralgia—Niacin—atherosclerosis	0.000191	0.00463	CcSEcCtD
Rosiglitazone—Myalgia—Niacin—atherosclerosis	0.000191	0.00463	CcSEcCtD
Rosiglitazone—Hypertension—Pravastatin—atherosclerosis	0.00019	0.00462	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00019	0.00461	CcSEcCtD
Rosiglitazone—Arthralgia—Pravastatin—atherosclerosis	0.000188	0.00456	CcSEcCtD
Rosiglitazone—Myalgia—Pravastatin—atherosclerosis	0.000188	0.00456	CcSEcCtD
Rosiglitazone—Fatigue—Lovastatin—atherosclerosis	0.000183	0.00445	CcSEcCtD
Rosiglitazone—Oedema—Niacin—atherosclerosis	0.000183	0.00444	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Niacin—atherosclerosis	0.000183	0.00444	CcSEcCtD
Rosiglitazone—PPARG—liver—atherosclerosis	0.000183	0.0139	CbGeAlD
Rosiglitazone—Constipation—Lovastatin—atherosclerosis	0.000182	0.00442	CcSEcCtD
Rosiglitazone—PTGS1—connective tissue—atherosclerosis	0.000181	0.0138	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000181	0.0044	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00018	0.00437	CcSEcCtD
Rosiglitazone—Asthenia—Rosuvastatin—atherosclerosis	0.00018	0.00437	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00018	0.00437	CcSEcCtD
Rosiglitazone—Oedema—Pravastatin—atherosclerosis	0.00018	0.00437	CcSEcCtD
Rosiglitazone—Fatigue—Ezetimibe—atherosclerosis	0.00018	0.00437	CcSEcCtD
Rosiglitazone—Infection—Pravastatin—atherosclerosis	0.000179	0.00434	CcSEcCtD
Rosiglitazone—Constipation—Ezetimibe—atherosclerosis	0.000178	0.00433	CcSEcCtD
Rosiglitazone—Pruritus—Rosuvastatin—atherosclerosis	0.000178	0.00431	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000176	0.00428	CcSEcCtD
Rosiglitazone—CYP2C9—cardiovascular system—atherosclerosis	0.000173	0.0132	CbGeAlD
Rosiglitazone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000172	0.00417	CcSEcCtD
Rosiglitazone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000172	0.00417	CcSEcCtD
Rosiglitazone—Fatigue—Simvastatin—atherosclerosis	0.000171	0.00416	CcSEcCtD
Rosiglitazone—ALB—liver—atherosclerosis	0.000171	0.013	CbGeAlD
Rosiglitazone—Constipation—Simvastatin—atherosclerosis	0.00017	0.00413	CcSEcCtD
Rosiglitazone—Urticaria—Lovastatin—atherosclerosis	0.000169	0.0041	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000166	0.00404	CcSEcCtD
Rosiglitazone—Dizziness—Rosuvastatin—atherosclerosis	0.000166	0.00403	CcSEcCtD
Rosiglitazone—Urticaria—Ezetimibe—atherosclerosis	0.000166	0.00402	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000164	0.00398	CcSEcCtD
Rosiglitazone—Rash—Rosuvastatin—atherosclerosis	0.000158	0.00384	CcSEcCtD
Rosiglitazone—Dermatitis—Rosuvastatin—atherosclerosis	0.000158	0.00384	CcSEcCtD
Rosiglitazone—Urticaria—Simvastatin—atherosclerosis	0.000158	0.00384	CcSEcCtD
Rosiglitazone—PTGS1—cardiovascular system—atherosclerosis	0.000158	0.012	CbGeAlD
Rosiglitazone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000158	0.00383	CcSEcCtD
Rosiglitazone—Headache—Rosuvastatin—atherosclerosis	0.000157	0.00382	CcSEcCtD
Rosiglitazone—Fatigue—Pravastatin—atherosclerosis	0.000155	0.00377	CcSEcCtD
Rosiglitazone—Constipation—Pravastatin—atherosclerosis	0.000154	0.00373	CcSEcCtD
Rosiglitazone—Asthenia—Lovastatin—atherosclerosis	0.000153	0.00371	CcSEcCtD
Rosiglitazone—Pruritus—Lovastatin—atherosclerosis	0.00015	0.00365	CcSEcCtD
Rosiglitazone—Asthenia—Ezetimibe—atherosclerosis	0.00015	0.00363	CcSEcCtD
Rosiglitazone—Nausea—Rosuvastatin—atherosclerosis	0.000149	0.00362	CcSEcCtD
Rosiglitazone—Pruritus—Ezetimibe—atherosclerosis	0.000148	0.00358	CcSEcCtD
Rosiglitazone—Diarrhoea—Lovastatin—atherosclerosis	0.000145	0.00353	CcSEcCtD
Rosiglitazone—Urticaria—Niacin—atherosclerosis	0.000145	0.00352	CcSEcCtD
Rosiglitazone—Urticaria—Pravastatin—atherosclerosis	0.000143	0.00347	CcSEcCtD
Rosiglitazone—Asthenia—Simvastatin—atherosclerosis	0.000143	0.00347	CcSEcCtD
Rosiglitazone—Diarrhoea—Ezetimibe—atherosclerosis	0.000143	0.00347	CcSEcCtD
Rosiglitazone—Pruritus—Simvastatin—atherosclerosis	0.000141	0.00342	CcSEcCtD
Rosiglitazone—Dizziness—Lovastatin—atherosclerosis	0.000141	0.00341	CcSEcCtD
Rosiglitazone—PTGS1—adipose tissue—atherosclerosis	0.000139	0.0106	CbGeAlD
Rosiglitazone—Dizziness—Ezetimibe—atherosclerosis	0.000138	0.00335	CcSEcCtD
Rosiglitazone—CYP2C19—liver—atherosclerosis	0.000138	0.0105	CbGeAlD
Rosiglitazone—Diarrhoea—Simvastatin—atherosclerosis	0.000136	0.00331	CcSEcCtD
Rosiglitazone—Rash—Lovastatin—atherosclerosis	0.000134	0.00326	CcSEcCtD
Rosiglitazone—Dermatitis—Lovastatin—atherosclerosis	0.000134	0.00325	CcSEcCtD
Rosiglitazone—Headache—Lovastatin—atherosclerosis	0.000133	0.00324	CcSEcCtD
Rosiglitazone—Dizziness—Simvastatin—atherosclerosis	0.000132	0.00319	CcSEcCtD
Rosiglitazone—Rash—Ezetimibe—atherosclerosis	0.000131	0.00319	CcSEcCtD
Rosiglitazone—Dermatitis—Ezetimibe—atherosclerosis	0.000131	0.00319	CcSEcCtD
Rosiglitazone—Asthenia—Niacin—atherosclerosis	0.000131	0.00318	CcSEcCtD
Rosiglitazone—Headache—Ezetimibe—atherosclerosis	0.000131	0.00317	CcSEcCtD
Rosiglitazone—Pruritus—Niacin—atherosclerosis	0.000129	0.00314	CcSEcCtD
Rosiglitazone—Asthenia—Pravastatin—atherosclerosis	0.000129	0.00313	CcSEcCtD
Rosiglitazone—Pruritus—Pravastatin—atherosclerosis	0.000127	0.00309	CcSEcCtD
Rosiglitazone—Nausea—Lovastatin—atherosclerosis	0.000126	0.00307	CcSEcCtD
Rosiglitazone—Rash—Simvastatin—atherosclerosis	0.000125	0.00305	CcSEcCtD
Rosiglitazone—Dermatitis—Simvastatin—atherosclerosis	0.000125	0.00304	CcSEcCtD
Rosiglitazone—Diarrhoea—Niacin—atherosclerosis	0.000125	0.00303	CcSEcCtD
Rosiglitazone—Headache—Simvastatin—atherosclerosis	0.000125	0.00303	CcSEcCtD
Rosiglitazone—Nausea—Ezetimibe—atherosclerosis	0.000124	0.00301	CcSEcCtD
Rosiglitazone—Diarrhoea—Pravastatin—atherosclerosis	0.000123	0.00299	CcSEcCtD
Rosiglitazone—Dizziness—Niacin—atherosclerosis	0.000121	0.00293	CcSEcCtD
Rosiglitazone—CYP2C8—liver—atherosclerosis	0.00012	0.00917	CbGeAlD
Rosiglitazone—Dizziness—Pravastatin—atherosclerosis	0.000119	0.00289	CcSEcCtD
Rosiglitazone—Nausea—Simvastatin—atherosclerosis	0.000118	0.00287	CcSEcCtD
Rosiglitazone—Rash—Niacin—atherosclerosis	0.000115	0.0028	CcSEcCtD
Rosiglitazone—Dermatitis—Niacin—atherosclerosis	0.000115	0.00279	CcSEcCtD
Rosiglitazone—Headache—Niacin—atherosclerosis	0.000114	0.00278	CcSEcCtD
Rosiglitazone—Rash—Pravastatin—atherosclerosis	0.000113	0.00275	CcSEcCtD
Rosiglitazone—Dermatitis—Pravastatin—atherosclerosis	0.000113	0.00275	CcSEcCtD
Rosiglitazone—Headache—Pravastatin—atherosclerosis	0.000113	0.00274	CcSEcCtD
Rosiglitazone—CYP1A2—liver—atherosclerosis	0.000113	0.00858	CbGeAlD
Rosiglitazone—Nausea—Niacin—atherosclerosis	0.000108	0.00263	CcSEcCtD
Rosiglitazone—CYP2C9—liver—atherosclerosis	0.000107	0.00814	CbGeAlD
Rosiglitazone—Nausea—Pravastatin—atherosclerosis	0.000107	0.00259	CcSEcCtD
Rosiglitazone—CYP2D6—liver—atherosclerosis	8.02e-05	0.00611	CbGeAlD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.92e-06	8.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	3.92e-06	8.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.92e-06	8.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.89e-06	8.48e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—LPL—atherosclerosis	3.89e-06	8.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS3—atherosclerosis	3.87e-06	8.42e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARA—atherosclerosis	3.86e-06	8.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOB—atherosclerosis	3.85e-06	8.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.84e-06	8.38e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.82e-06	8.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.81e-06	8.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.81e-06	8.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.8e-06	8.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SCARB1—atherosclerosis	3.8e-06	8.28e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPX1—atherosclerosis	3.79e-06	8.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALOX5—atherosclerosis	3.79e-06	8.26e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SCARB1—atherosclerosis	3.78e-06	8.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA2—atherosclerosis	3.77e-06	8.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	3.77e-06	8.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX15—atherosclerosis	3.77e-06	8.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	3.77e-06	8.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.76e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTM1—atherosclerosis	3.74e-06	8.16e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AGT—atherosclerosis	3.74e-06	8.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCG5—atherosclerosis	3.73e-06	8.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.72e-06	8.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.7e-06	8.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NAMPT—atherosclerosis	3.69e-06	8.05e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CD36—atherosclerosis	3.69e-06	8.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—LPL—atherosclerosis	3.67e-06	8.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.67e-06	8.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LIPC—atherosclerosis	3.67e-06	8e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—atherosclerosis	3.66e-06	7.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOC3—atherosclerosis	3.65e-06	7.95e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—atherosclerosis	3.64e-06	7.94e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CAV1—atherosclerosis	3.63e-06	7.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LDLR—atherosclerosis	3.63e-06	7.9e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOA1—atherosclerosis	3.62e-06	7.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPA—atherosclerosis	3.6e-06	7.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMGCR—atherosclerosis	3.59e-06	7.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPX1—atherosclerosis	3.58e-06	7.81e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMGCR—atherosclerosis	3.57e-06	7.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CETP—atherosclerosis	3.54e-06	7.72e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTHFR—atherosclerosis	3.5e-06	7.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD36—atherosclerosis	3.49e-06	7.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BGN—atherosclerosis	3.49e-06	7.6e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NOS3—atherosclerosis	3.48e-06	7.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.47e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.46e-06	7.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA5—atherosclerosis	3.45e-06	7.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.45e-06	7.51e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARA—atherosclerosis	3.43e-06	7.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NAMPT—atherosclerosis	3.4e-06	7.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SCARB1—atherosclerosis	3.39e-06	7.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LIPC—atherosclerosis	3.38e-06	7.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.37e-06	7.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOC3—atherosclerosis	3.36e-06	7.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.35e-06	7.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.35e-06	7.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LIPC—atherosclerosis	3.35e-06	7.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LDLR—atherosclerosis	3.34e-06	7.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOC3—atherosclerosis	3.33e-06	7.25e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AGT—atherosclerosis	3.32e-06	7.25e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	3.32e-06	7.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—atherosclerosis	3.31e-06	7.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LDLR—atherosclerosis	3.31e-06	7.21e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	3.3e-06	7.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.3e-06	7.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.29e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CETP—atherosclerosis	3.26e-06	7.1e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—atherosclerosis	3.26e-06	7.1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.26e-06	7.1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.25e-06	7.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARA—atherosclerosis	3.25e-06	7.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.24e-06	7.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CETP—atherosclerosis	3.23e-06	7.04e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CAV1—atherosclerosis	3.23e-06	7.03e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—atherosclerosis	3.22e-06	7.02e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.22e-06	7.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX5—atherosclerosis	3.21e-06	7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMGCR—atherosclerosis	3.2e-06	6.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.2e-06	6.97e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—atherosclerosis	3.19e-06	6.95e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—atherosclerosis	3.19e-06	6.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCA1—atherosclerosis	3.18e-06	6.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—atherosclerosis	3.14e-06	6.85e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—INS—atherosclerosis	3.13e-06	6.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.12e-06	6.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.09e-06	6.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—atherosclerosis	3.08e-06	6.71e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—atherosclerosis	3.05e-06	6.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CAV1—atherosclerosis	3.05e-06	6.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—atherosclerosis	3.04e-06	6.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.01e-06	6.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.97e-06	6.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.95e-06	6.42e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—atherosclerosis	2.94e-06	6.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.92e-06	6.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.89e-06	6.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.88e-06	6.27e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—atherosclerosis	2.87e-06	6.25e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.86e-06	6.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—atherosclerosis	2.86e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCA1—atherosclerosis	2.85e-06	6.22e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOC3—atherosclerosis	2.84e-06	6.2e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—atherosclerosis	2.84e-06	6.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LDLR—atherosclerosis	2.83e-06	6.16e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—atherosclerosis	2.78e-06	6.07e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—INS—atherosclerosis	2.78e-06	6.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—atherosclerosis	2.78e-06	6.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—atherosclerosis	2.76e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—atherosclerosis	2.74e-06	5.98e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—atherosclerosis	2.74e-06	5.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—atherosclerosis	2.73e-06	5.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—atherosclerosis	2.68e-06	5.85e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SCARB1—atherosclerosis	2.64e-06	5.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.63e-06	5.74e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—atherosclerosis	2.63e-06	5.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—INS—atherosclerosis	2.63e-06	5.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOB—atherosclerosis	2.63e-06	5.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCA1—atherosclerosis	2.63e-06	5.72e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOB—atherosclerosis	2.61e-06	5.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.6e-06	5.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.57e-06	5.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.56e-06	5.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—atherosclerosis	2.56e-06	5.57e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—atherosclerosis	2.55e-06	5.56e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—atherosclerosis	2.54e-06	5.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—atherosclerosis	2.51e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—atherosclerosis	2.51e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.5e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—atherosclerosis	2.5e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—atherosclerosis	2.45e-06	5.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—atherosclerosis	2.45e-06	5.34e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—atherosclerosis	2.44e-06	5.32e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—atherosclerosis	2.43e-06	5.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—atherosclerosis	2.41e-06	5.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—atherosclerosis	2.38e-06	5.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—atherosclerosis	2.37e-06	5.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOB—atherosclerosis	2.35e-06	5.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—atherosclerosis	2.31e-06	5.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.28e-06	4.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.26e-06	4.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.25e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.25e-06	4.91e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—atherosclerosis	2.25e-06	4.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—atherosclerosis	2.24e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.23e-06	4.87e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—atherosclerosis	2.23e-06	4.86e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.22e-06	4.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARA—atherosclerosis	2.22e-06	4.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARA—atherosclerosis	2.2e-06	4.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—atherosclerosis	2.19e-06	4.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOB—atherosclerosis	2.16e-06	4.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—atherosclerosis	2.15e-06	4.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOB—atherosclerosis	2.14e-06	4.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—atherosclerosis	2.13e-06	4.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—atherosclerosis	2.13e-06	4.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—atherosclerosis	2.11e-06	4.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—atherosclerosis	2.1e-06	4.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.1e-06	4.58e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—atherosclerosis	2.09e-06	4.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAV1—atherosclerosis	2.08e-06	4.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.08e-06	4.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—atherosclerosis	2.08e-06	4.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAV1—atherosclerosis	2.07e-06	4.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—atherosclerosis	2.07e-06	4.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—atherosclerosis	2.06e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—atherosclerosis	2.06e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—atherosclerosis	2.04e-06	4.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.02e-06	4.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—atherosclerosis	2.01e-06	4.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—atherosclerosis	1.99e-06	4.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARA—atherosclerosis	1.98e-06	4.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—atherosclerosis	1.96e-06	4.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—atherosclerosis	1.94e-06	4.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—atherosclerosis	1.92e-06	4.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.91e-06	4.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.9e-06	4.14e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—atherosclerosis	1.89e-06	4.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—atherosclerosis	1.88e-06	4.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAV1—atherosclerosis	1.86e-06	4.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—atherosclerosis	1.86e-06	4.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.86e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.84e-06	4.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—atherosclerosis	1.83e-06	3.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOB—atherosclerosis	1.83e-06	3.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—atherosclerosis	1.82e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARA—atherosclerosis	1.82e-06	3.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARA—atherosclerosis	1.8e-06	3.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—INS—atherosclerosis	1.8e-06	3.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—INS—atherosclerosis	1.79e-06	3.9e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.78e-06	3.88e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—atherosclerosis	1.78e-06	3.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—atherosclerosis	1.76e-06	3.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—atherosclerosis	1.75e-06	3.81e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—atherosclerosis	1.75e-06	3.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—atherosclerosis	1.73e-06	3.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—atherosclerosis	1.71e-06	3.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAV1—atherosclerosis	1.71e-06	3.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—atherosclerosis	1.71e-06	3.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—atherosclerosis	1.7e-06	3.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAV1—atherosclerosis	1.7e-06	3.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.69e-06	3.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—atherosclerosis	1.69e-06	3.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—atherosclerosis	1.66e-06	3.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—atherosclerosis	1.65e-06	3.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—atherosclerosis	1.64e-06	3.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—INS—atherosclerosis	1.6e-06	3.5e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—atherosclerosis	1.6e-06	3.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—atherosclerosis	1.58e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.57e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—atherosclerosis	1.57e-06	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.56e-06	3.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.55e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARA—atherosclerosis	1.54e-06	3.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—atherosclerosis	1.5e-06	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—atherosclerosis	1.49e-06	3.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—atherosclerosis	1.49e-06	3.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—INS—atherosclerosis	1.48e-06	3.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—atherosclerosis	1.47e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—atherosclerosis	1.46e-06	3.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—INS—atherosclerosis	1.46e-06	3.19e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAV1—atherosclerosis	1.45e-06	3.16e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—atherosclerosis	1.45e-06	3.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.44e-06	3.14e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—atherosclerosis	1.43e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—atherosclerosis	1.41e-06	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—atherosclerosis	1.35e-06	2.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—atherosclerosis	1.34e-06	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.32e-06	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—atherosclerosis	1.29e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.29e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—atherosclerosis	1.28e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—atherosclerosis	1.27e-06	2.78e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.26e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—INS—atherosclerosis	1.25e-06	2.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.18e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.17e-06	2.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—atherosclerosis	1.15e-06	2.5e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—atherosclerosis	1.12e-06	2.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—atherosclerosis	1.1e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—atherosclerosis	1.06e-06	2.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—atherosclerosis	1e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—atherosclerosis	7.25e-07	1.58e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—atherosclerosis	7.2e-07	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—atherosclerosis	6.47e-07	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—atherosclerosis	5.95e-07	1.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—atherosclerosis	5.9e-07	1.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—atherosclerosis	5.04e-07	1.1e-05	CbGpPWpGaD
